As a leading staffing specialist with offices in the UK, Europe and North America our biggest USP is representing candidates of all levels across Research & Development, Operational Excellence & Performance, Manufacturing Quality, Compliance, Regulation, Data Management, Cost Optimisation and Innovation. We pride ourselves on being able to deliver to almost every requirement in your business, in any location you need it.
Take a look at our specialist areas covered across the USA.
SciPro is a people business. We specialise in sourcing, advising and introducing highly skilled life sciences candidates to our client partners across the globe, helping them to achieve their business goals. The art of recruitment isn't solely about filling jobs, it's about matching people with people and creating harmonious and successful working environments. As a leading staffing specialist with offices in the UK, Europe and North America our biggest USP is representing candidates of all levels across Research & Development, Operational Excellence & Performance, Manufacturing Quality, Compliance, Regulation, Data Management, Cost Optimisation and Innovation. We pride ourselves on being able to deliver to almost every requirement in your business, in any location you need it.
SciPro is a people business. We specialise in sourcing, advising and introducing highly skilled life sciences candidates to our client partners across the globe, helping them to achieve their business goals. The art of recruitment isn't solely about filling jobs, it's about matching people with people and creating harmonious and successful working environments. As a leading staffing specialist with offices in the UK, Europe and North America our biggest USP is representing candidates of all levels across Research & Development, Operational Excellence & Performance, Manufacturing Quality, Compliance, Regulation, Data Management, Cost Optimisation and Innovation. We pride ourselves on being able to deliver to almost every requirement in your business, in any location you need it.
We're a specialist global team, which means you get access to the best Life Sciences candidates in the world. You can rely on us to deliver across all of your locations.
As a global recruitment organisation EPM Scientific works exclusively within Life Science, we recognise that continuous
development within the industry can make the ability to attract and retain top talent a key priority.
Your career is alive!
As part of our team, people around the world will count on your talent, expertise and knowledge. That’s what happens when the work you do saves lives in more than 80 countries.
All of a sudden, going to work takes on a whole new meaning. You’re no longer waking up each morning just for yourself – you’re making a far-reaching impact every day. Combine that with advancement opportunities, great benefits and company-wide support, and you have plenty of reasons to wake up your talent.
The increased availability of biomedical data, particularly in the public domain, offers the opportunity to better understand human health and to develop effective therapeutics for a wide range of unmet medical needs. However, data scientists remain stymied by the fact that data remain hard to find and to productively reuse because data and their metadata i) are wholly inaccessible, ii) are in non-standard or incompatible representations, iii) do not conform to community standards, and iv) have unclear or highly restricted terms and conditions that preclude legitimate reuse. These limitations require a rethink on data can be made machine and AI-ready - the key motivation behind the FAIR Guiding Principles. Concurrently, while recent efforts have explored the use of deep learning to fuse disparate data into predictive models for a wide range of biomedical applications, these models often fail even when the correct answer is already known, and fail to explain individual predictions in terms that data scientists can appreciate. These limitations suggest that new methods to produce practical artificial intelligence are still needed.
In this talk, I will discuss our work in (1) building an integrative knowledge infrastructure to prepare FAIR and "AI-ready" data and services along with (2) neurosymbolic AI methods to improve the quality of predictions and to generate plausible explanations. Attention is given to standards, platforms, and methods to wrangle knowledge into simple, but effective semantic and latent representations, and to make these available into standards-compliant and discoverable interfaces that can be used in model building, validation, and explanation. Our work, and those of others in the field, creates a baseline for building trustworthy and easy to deploy AI models in biomedicine.
Bio
Dr. Michel Dumontier is the Distinguished Professor of Data Science at Maastricht University, founder and executive director of the Institute of Data Science, and co-founder of the FAIR (Findable, Accessible, Interoperable and Reusable) data principles. His research explores socio-technological approaches for responsible discovery science, which includes collaborative multi-modal knowledge graphs, privacy-preserving distributed data mining, and AI methods for drug discovery and personalized medicine. His work is supported through the Dutch National Research Agenda, the Netherlands Organisation for Scientific Research, Horizon Europe, the European Open Science Cloud, the US National Institutes of Health, and a Marie-Curie Innovative Training Network. He is the editor-in-chief for the journal Data Science and is internationally recognized for his contributions in bioinformatics, biomedical informatics, and semantic technologies including ontologies and linked data.
A brief information about the SCOP protein database used in bioinformatics.
The Structural Classification of Proteins (SCOP) database is a comprehensive and authoritative resource for the structural and evolutionary relationships of proteins. It provides a detailed and curated classification of protein structures, grouping them into families, superfamilies, and folds based on their structural and sequence similarities.
Cancer cell metabolism: special Reference to Lactate PathwayAADYARAJPANDEY1
Normal Cell Metabolism:
Cellular respiration describes the series of steps that cells use to break down sugar and other chemicals to get the energy we need to function.
Energy is stored in the bonds of glucose and when glucose is broken down, much of that energy is released.
Cell utilize energy in the form of ATP.
The first step of respiration is called glycolysis. In a series of steps, glycolysis breaks glucose into two smaller molecules - a chemical called pyruvate. A small amount of ATP is formed during this process.
Most healthy cells continue the breakdown in a second process, called the Kreb's cycle. The Kreb's cycle allows cells to “burn” the pyruvates made in glycolysis to get more ATP.
The last step in the breakdown of glucose is called oxidative phosphorylation (Ox-Phos).
It takes place in specialized cell structures called mitochondria. This process produces a large amount of ATP. Importantly, cells need oxygen to complete oxidative phosphorylation.
If a cell completes only glycolysis, only 2 molecules of ATP are made per glucose. However, if the cell completes the entire respiration process (glycolysis - Kreb's - oxidative phosphorylation), about 36 molecules of ATP are created, giving it much more energy to use.
IN CANCER CELL:
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
Unlike healthy cells that "burn" the entire molecule of sugar to capture a large amount of energy as ATP, cancer cells are wasteful.
Cancer cells only partially break down sugar molecules. They overuse the first step of respiration, glycolysis. They frequently do not complete the second step, oxidative phosphorylation.
This results in only 2 molecules of ATP per each glucose molecule instead of the 36 or so ATPs healthy cells gain. As a result, cancer cells need to use a lot more sugar molecules to get enough energy to survive.
introduction to WARBERG PHENOMENA:
WARBURG EFFECT Usually, cancer cells are highly glycolytic (glucose addiction) and take up more glucose than do normal cells from outside.
Otto Heinrich Warburg (; 8 October 1883 – 1 August 1970) In 1931 was awarded the Nobel Prize in Physiology for his "discovery of the nature and mode of action of the respiratory enzyme.
WARNBURG EFFECT : cancer cells under aerobic (well-oxygenated) conditions to metabolize glucose to lactate (aerobic glycolysis) is known as the Warburg effect. Warburg made the observation that tumor slices consume glucose and secrete lactate at a higher rate than normal tissues.
(May 29th, 2024) Advancements in Intravital Microscopy- Insights for Preclini...Scintica Instrumentation
Intravital microscopy (IVM) is a powerful tool utilized to study cellular behavior over time and space in vivo. Much of our understanding of cell biology has been accomplished using various in vitro and ex vivo methods; however, these studies do not necessarily reflect the natural dynamics of biological processes. Unlike traditional cell culture or fixed tissue imaging, IVM allows for the ultra-fast high-resolution imaging of cellular processes over time and space and were studied in its natural environment. Real-time visualization of biological processes in the context of an intact organism helps maintain physiological relevance and provide insights into the progression of disease, response to treatments or developmental processes.
In this webinar we give an overview of advanced applications of the IVM system in preclinical research. IVIM technology is a provider of all-in-one intravital microscopy systems and solutions optimized for in vivo imaging of live animal models at sub-micron resolution. The system’s unique features and user-friendly software enables researchers to probe fast dynamic biological processes such as immune cell tracking, cell-cell interaction as well as vascularization and tumor metastasis with exceptional detail. This webinar will also give an overview of IVM being utilized in drug development, offering a view into the intricate interaction between drugs/nanoparticles and tissues in vivo and allows for the evaluation of therapeutic intervention in a variety of tissues and organs. This interdisciplinary collaboration continues to drive the advancements of novel therapeutic strategies.
Richard's entangled aventures in wonderlandRichard Gill
Since the loophole-free Bell experiments of 2020 and the Nobel prizes in physics of 2022, critics of Bell's work have retreated to the fortress of super-determinism. Now, super-determinism is a derogatory word - it just means "determinism". Palmer, Hance and Hossenfelder argue that quantum mechanics and determinism are not incompatible, using a sophisticated mathematical construction based on a subtle thinning of allowed states and measurements in quantum mechanics, such that what is left appears to make Bell's argument fail, without altering the empirical predictions of quantum mechanics. I think however that it is a smoke screen, and the slogan "lost in math" comes to my mind. I will discuss some other recent disproofs of Bell's theorem using the language of causality based on causal graphs. Causal thinking is also central to law and justice. I will mention surprising connections to my work on serial killer nurse cases, in particular the Dutch case of Lucia de Berk and the current UK case of Lucy Letby.
Slide 1: Title Slide
Extrachromosomal Inheritance
Slide 2: Introduction to Extrachromosomal Inheritance
Definition: Extrachromosomal inheritance refers to the transmission of genetic material that is not found within the nucleus.
Key Components: Involves genes located in mitochondria, chloroplasts, and plasmids.
Slide 3: Mitochondrial Inheritance
Mitochondria: Organelles responsible for energy production.
Mitochondrial DNA (mtDNA): Circular DNA molecule found in mitochondria.
Inheritance Pattern: Maternally inherited, meaning it is passed from mothers to all their offspring.
Diseases: Examples include Leber’s hereditary optic neuropathy (LHON) and mitochondrial myopathy.
Slide 4: Chloroplast Inheritance
Chloroplasts: Organelles responsible for photosynthesis in plants.
Chloroplast DNA (cpDNA): Circular DNA molecule found in chloroplasts.
Inheritance Pattern: Often maternally inherited in most plants, but can vary in some species.
Examples: Variegation in plants, where leaf color patterns are determined by chloroplast DNA.
Slide 5: Plasmid Inheritance
Plasmids: Small, circular DNA molecules found in bacteria and some eukaryotes.
Features: Can carry antibiotic resistance genes and can be transferred between cells through processes like conjugation.
Significance: Important in biotechnology for gene cloning and genetic engineering.
Slide 6: Mechanisms of Extrachromosomal Inheritance
Non-Mendelian Patterns: Do not follow Mendel’s laws of inheritance.
Cytoplasmic Segregation: During cell division, organelles like mitochondria and chloroplasts are randomly distributed to daughter cells.
Heteroplasmy: Presence of more than one type of organellar genome within a cell, leading to variation in expression.
Slide 7: Examples of Extrachromosomal Inheritance
Four O’clock Plant (Mirabilis jalapa): Shows variegated leaves due to different cpDNA in leaf cells.
Petite Mutants in Yeast: Result from mutations in mitochondrial DNA affecting respiration.
Slide 8: Importance of Extrachromosomal Inheritance
Evolution: Provides insight into the evolution of eukaryotic cells.
Medicine: Understanding mitochondrial inheritance helps in diagnosing and treating mitochondrial diseases.
Agriculture: Chloroplast inheritance can be used in plant breeding and genetic modification.
Slide 9: Recent Research and Advances
Gene Editing: Techniques like CRISPR-Cas9 are being used to edit mitochondrial and chloroplast DNA.
Therapies: Development of mitochondrial replacement therapy (MRT) for preventing mitochondrial diseases.
Slide 10: Conclusion
Summary: Extrachromosomal inheritance involves the transmission of genetic material outside the nucleus and plays a crucial role in genetics, medicine, and biotechnology.
Future Directions: Continued research and technological advancements hold promise for new treatments and applications.
Slide 11: Questions and Discussion
Invite Audience: Open the floor for any questions or further discussion on the topic.
Introduction:
RNA interference (RNAi) or Post-Transcriptional Gene Silencing (PTGS) is an important biological process for modulating eukaryotic gene expression.
It is highly conserved process of posttranscriptional gene silencing by which double stranded RNA (dsRNA) causes sequence-specific degradation of mRNA sequences.
dsRNA-induced gene silencing (RNAi) is reported in a wide range of eukaryotes ranging from worms, insects, mammals and plants.
This process mediates resistance to both endogenous parasitic and exogenous pathogenic nucleic acids, and regulates the expression of protein-coding genes.
What are small ncRNAs?
micro RNA (miRNA)
short interfering RNA (siRNA)
Properties of small non-coding RNA:
Involved in silencing mRNA transcripts.
Called “small” because they are usually only about 21-24 nucleotides long.
Synthesized by first cutting up longer precursor sequences (like the 61nt one that Lee discovered).
Silence an mRNA by base pairing with some sequence on the mRNA.
Discovery of siRNA?
The first small RNA:
In 1993 Rosalind Lee (Victor Ambros lab) was studying a non- coding gene in C. elegans, lin-4, that was involved in silencing of another gene, lin-14, at the appropriate time in the
development of the worm C. elegans.
Two small transcripts of lin-4 (22nt and 61nt) were found to be complementary to a sequence in the 3' UTR of lin-14.
Because lin-4 encoded no protein, she deduced that it must be these transcripts that are causing the silencing by RNA-RNA interactions.
Types of RNAi ( non coding RNA)
MiRNA
Length (23-25 nt)
Trans acting
Binds with target MRNA in mismatch
Translation inhibition
Si RNA
Length 21 nt.
Cis acting
Bind with target Mrna in perfect complementary sequence
Piwi-RNA
Length ; 25 to 36 nt.
Expressed in Germ Cells
Regulates trnasposomes activity
MECHANISM OF RNAI:
First the double-stranded RNA teams up with a protein complex named Dicer, which cuts the long RNA into short pieces.
Then another protein complex called RISC (RNA-induced silencing complex) discards one of the two RNA strands.
The RISC-docked, single-stranded RNA then pairs with the homologous mRNA and destroys it.
THE RISC COMPLEX:
RISC is large(>500kD) RNA multi- protein Binding complex which triggers MRNA degradation in response to MRNA
Unwinding of double stranded Si RNA by ATP independent Helicase
Active component of RISC is Ago proteins( ENDONUCLEASE) which cleave target MRNA.
DICER: endonuclease (RNase Family III)
Argonaute: Central Component of the RNA-Induced Silencing Complex (RISC)
One strand of the dsRNA produced by Dicer is retained in the RISC complex in association with Argonaute
ARGONAUTE PROTEIN :
1.PAZ(PIWI/Argonaute/ Zwille)- Recognition of target MRNA
2.PIWI (p-element induced wimpy Testis)- breaks Phosphodiester bond of mRNA.)RNAse H activity.
MiRNA:
The Double-stranded RNAs are naturally produced in eukaryotic cells during development, and they have a key role in regulating gene expression .
2. SciPro is a people business. We specialise in sourcing, advising and introducing highly skilled life sciences
candidates to our client partners across the globe, helping them to achieve their business goals.
The art of recruitment isn't solely about filling jobs, it's about matching people with people and creating
harmonious and successful working environments.
As a leading staffing specialist with offices in North America and Europe, our biggest USP is representing
candidates of all levels across Research & Development, Operational Excellence & Performance, Manufacturing
Quality, Compliance, Regulation, Data Management, Cost Optimization and Innovation. We pride ourselves on
being able to deliver to almost every requirement in your business, in any location you need it.
What we do
For candidates looking for their next role, it’s so important to gain an understanding and insight in to a potential
new company.
Because we partner so closely to the businesses we work with we are able to really match candidates with
opportunities and they can trust our consultation on company culture, reporting structure, growth plans and
everything that could effect their working life. We believe in so much more than just matching skills to jobs.
How we can help you
Our service is about getting under the skin of requirements, advising on current and future staffing needs,
adopting the company values and representing the employer brand. We are committed to understanding
candidates motivation, experience, character and career goals to truly match them with the right opportunity.
Our consultants are technically aligned specialists focusing on a single area within Quality, Regulatory Affairs,
Clinical Operations & Development, Data Management, Project Management, Medical Affairs, Pharmacovigilance,
Market Access & HEOR, Research & Development, Biometrics and Medical Devices.
With the Life Science industry experiencing unparalleled growth, SciPro is committed to working in partnership
with Pharmaceutical, Biotech and Medical Devices companies to supply exceptional talent to support this.
Why choose SciPro?
For clients and candidates alike, the reasons to work with SciPro are the same.
We have a tailored approach to job search. No two people, two requirements or two businesses are the same.
We have a candidate and client promise that is based on listening first, advising second. We will give bespoke
consultation for your individual needs. Our first stage is understanding what are the most important elements
for your decision and then making sure those elements are never forgotten.
“The service that we have received
has been excellent, in particular our
consultant who has a professional, friendly
manner, managing both the company
and the candidates expectations well,
demonstrating discretion at all times. It is
essential that candidates are matched to
the specific needs of our business, SciPro
has listened to our specific needs. I would
have no hesitation in working with, or
recommending to others in future.”
HR Manager, Pharmaceutical company
About us
3. Biotech
Our clients are providing breakthrough products and technologies to improve our lives and the health of our
planet. Technology based on biology is enabling the world to deal with some of society’s biggest challenges
from food to diseases and greenhouse gas emissions. Here at SciPro we have built teams dedicated to
identifying talent that can positively impact our customers and add value to the projects they are running and
products they are developing.
Our specialism includes roles within:
Research & Development
Pharmacogenomics
Gene & Cell Therapy
Quality Assurance & Control
Regulatory
Commercial
Pre-Clinical & Clinical
Manufacturing & Production
Clinical Development
Bioprocessing
Bioinformatics
Upstream & Downstream
Processing Analytica
Microbiology
Technical Sales
Validation
Product Characterization
Program Management
“
We have built
teams dedicated
to identifying
talent that
can positively
impact our
customers and
add value to the
projects they are
running.
4. Pharmaceuticals
The Pharmaceutical industry is ever evolving with SciPro leading in delivering world class talent to support,
expand and innovate within the market. Covering specialist skills for start-up organizations, SME businesses,
Global Leaders and CROs we have developed unique networks with exclusive talent pools to ensure we can
offer choice to our chosen industry partners.
Working within such a fluid and niche industry, SciPro recognize the increasing demand for character and not
just technical skill. In an industry where making a difference to a patient-centric environment is vital, we offer
value on making sure your individual needs are met with the right ‘fit’. Our clients and candidates are equally
unique in their approaches, so making sure we introduce the right skills, with the right attitude sets us apart.
Understanding what is important to you and your challenges is an essential part of the process to ensure we
are making the correct introductions to both candidates and clients alike.
Our specialism includes roles within:
Quality
Regulatory Affairs
Clinical Operations
Clinical Development
Pharmacovigilance & Drug Safety
Commercial Operations
Biometrics
Medical Affairs
Sales & Marketing
“
Working with
such a fluid and
niche industry,
SciPro recognize
the increasing
demand for
character
and not just
technical skill.
5. Medical Devices
The Medical Devices industry is fundamental to a developing world of innovation within the Healthcare sector.
We understand how the impact of regulatory change, funding and advancements in technology affect talent
acquisition for our clients.
In an industry where talent is in short supply, our focus is on building global candidate communities that are
unique to SciPro. Through offering our clients access to these communities, we are able to deliver talent that
positively impacts across the Medical Device Life-Cycle.
Our specialism includes roles within:
Engineering
Quality
Design
Validation
Regulatory Affairs
Product Management
Operations
Sales & Marketing
“
In an industry
where talent is
in short supply,
our focus is on
building global
candidate
communities
that are unique
to SciPro.
6. In line with our clients growth and the future of Life Sciences we have
expanded internationally with offices in North America and Europe. Our
SciPro offices spread across a number of regions in the US and Europe;
Santa Monica, San Francisco, New York, London & Munich.
Global Presence
London
Santa
Monica
New
York
MunichSan
Francisco
7. SciPro offers you the right amount of expertise, passion and quality.
As an innovative company in a very challenging industry, we create tailor-made solutions in order to
achieve ultimate success for you. We at SciPro benefit from an international presence and a strong
infrastructure, which helps us and our team to support your needs. Based in four offices internationally,
we have an incredible management team led by Tom Glanfield (CEO), Benjamin Richardson (Head of LHi
Group, West Coast) and Julian Landsberg (Head of SciPro, East Coast), with specialist permanent and
contract teams.
Meet the team
Tom Glanfield
CEO & Founder
Tom founded SciPro, formerly Lawrence Harvey Life Sciences, in 2002, and with
the support of the other leaders on this page, they have combined a successful
strategy of organic growth and raw ambition, and together have built SciPro into
a multi-national thriving entity. He spends most of his time between the USA and
Europe visiting our international offices. His mission is continued growth and
further global domination... just watch this space.
Julian Landsberg
Vice President - Head of SciPro, East Coast
Julian was brought in to SciPro to specifically develop our US presence, with a
special focus on the East Coast region. His team work across the US Life Sciences
market, specializing on the Quality Assurance, Regulatory Affairs and end-to-end
Supply Chain verticals.
Benjamin Richardson
Senior Vice President - Head of LHi Group, West Coast
Ben focuses on leading and growing the SciPro brand covering the West Coast
region. His team is divided up into core disciplines to support our Biotechnology,
Pharmaceuticals, Medical Devices, and Diagnostics clients, cross-functionally.
From Clinical to Legal and everything between.
We think the
Life Science
industry in
the US is
inspiring.
Therefore,
we are highly
motivated to
support the
growth of your
company.
“
8. Candidate Testimonials
SciPro were a pleasure to work with throughout my job application process. They kept
me up to date at every step of the way and were thoroughly pro-active in finding out
answers to my queries. They ensured feedback after each interview was provided to
me as soon as possible and have continued to follow up with me after starting my new
role. They work in a friendly and professional manner. I would definitely contact SciPro
again if I were to be looking for a new role.
Regulatory Affairs Project Manager
“
Pavlina Bullaj
Executive Recruiter
I really enjoyed working with SciPro throughout the recruitment process. They are
exceptionally professional, responsive, and knowledgeable. Throughout the interview
process, they were a fantastic resource regarding the company, and were a tremendous help
when preparing me for the interview. I would highly recommend SciPro to anyone looking
for a position in the pharma industry.
Director, Regulatory Affairs
“ Kyle Murfin
Senior Consultant
My consultant is a strong recruitment specialist and who has taken the time to understand
who I am and what I was looking for as a career path. Their attention to detail is remarkable,
as they take note of skill-set, professional aptitude, remuneration requirements, long-term
career path, personal development, and so forth. I have never before been so well matched
to, or briefed for a recruitment process. From the initial selection to the final package
negotiations, SciPro’s guidance and support were invaluable.
Senior Regulatory Affairs Manager
“
Imogen Simpkin
Senior Consultant
SciPro helped me throughout the application process for my current job. They always made
sure I was well prepared before interview and offered support all the way. They are great
communicators and are a pleasure to work with. They doubtlessly take their job very seriously.
Regulatory Affairs Consultant
“
I’ve had the pleasure of working with SciPro directly. They are true professionals with a warm
demeanour about them. Their ability to understand both client’s and candidate’s needs is
impeccable. They are truly focused on ensuring that both client and candidate are an ideal
fit and their follow through is above par. I have thoroughly enjoyed getting to know my
consultant and would recommend SciPro with the highest regard.
SVP, Medical Affairs
“
Reece Mitellas
Senior Consultant
With 15+ years in the pharmaceutical industry, I do currently experience a rare occurrence in
the recruitment business: careful, systematic and long-lasting nurturing of the agency-
employee relationship. This is the SciPro professionals. My consultant has proven
instrumental and highly effective in securing my latest broad-scope, senior role in the bio-
similar business, despite many challenges and bottle-necks we have come across together.
I wish his knowledge, experience and psychological insight would be a more common
occurrence among head-hunters of other recruitment agencies
Senior Consultant, Biopharmaceuticals
“
SciPro successfully master a wide range of recruitment techniques. They make realistic and
positive descriptions of the organizations they represents. Their selection process is not
based merely on a Resume analysis, but on both telephone and face-to-face interviews. The
attention for details allow candidates to focus principally on their interview, as they take care
of all the rest. If I had to describe SciPro in a few words I would say; professional, hardworking
and very agreeable to work with.
Senior Regulatory Affairs Manager
“
9. Client Testimonials
I engaged SciPro for our Quality Manager vacancy as they had previously supplied us with
an extremely talented Medical Device professional that is still with us today.
Hiring is never easy for us due to our location, however, within one week my consultant was
able to present us with some excellent profiles which were clearly well qualified against the
job description. The interview process was smooth and efficient, and we were able to secure
our first choice candidate, within budget, as our consultant had targeted someone with
a clear and valid reason for seeking a new opportunity. We look forward to working with
SciPro again in the future.
Medical Devices Director
“
I found SciPro to be the ideal strategic recruitment partner. My consultant demonstrated
discretion, understanding of complex assignments, internal company preferences and most
importantly the ability to listen with care and delivered candidates who met our
exact needs.
The entire team at SciPro were always quick to make assignments work, demonstrated
great flexibility and were understanding of changing priority. A great company who I will be
re-engaging with again in the future.
Senior Director, Quality Operations
“
A massive thank you to SciPro for all of their help over the past year. This was my first time
working with a recruiter to find candidates (as opposed to being a candidate) and I really
appreciated all of their guidance, advice and follow-ups.
We gave them some real challenges with our candidate requirements but they listened
and adapted their searches based on our feedback, and it was obvious that they were
customizing the candidate list based on what we were telling them. I can’t thank them
enough for making this a relatively painless exercise in finding three new contract
employees for me.
Director, CMC
“
We engaged SciPro in a retained role to find suitable candidates for our specialist
regulatory consultancy. The brief was challenging, requiring experience in multiple areas
of Regulatory Affairs, especially with advanced therapies and preferably with client facing
consultancy experience and a willingness to work in our Cambridge office. SciPro found
five candidates in a timely manner, all of whom had positive attributes. We were then able
to quickly establish the best fit for our circumstances and bring the individual on board. I
would have no hesitation engaging SciPro again. If you are a future client looking for a
recruiter who is a specialist in Regulatory Affairs and really understands their market, I
would highly recommend SciPro.
Director of Regulatory Affairs
“
Benjamin Richardson
Senior Vice President
Kyle Murfin
Senior Consultant
The service that we have received has been excellent, in particular our consultant who
has a professional, friendly manner, managing both the company and the candidates
expectations well, demonstrating discretion at all times.
It is essential that candidates are matched to the specific needs of our business, SciPro has
listened to our specific needs.
I would have no hesitation in working with, or recommending to others in future.
HR Manager, Pharmaceuticals
“
Pavlina Bullaj
Executive Recruiter
Imogen Simpkin
Senior Consultant
10. For more information on our services, please contact:
Benjamin Richardson
Senior Vice President - Head of LHi Group, West Coast
+1 424-835-5912 | b.richardson@sciproglobal.com
Check out our industry insights: insights.sciproglobal.com
www.sciproglobal.com
